News
Valneva starts MHRA regulatory process for COVID-19 vaccine
Valneva has launched rolling submission for initial approval of its COVID-19 vaccine candidate VLA2001 with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Valneva has launched rolling submission for initial approval of its COVID-19 vaccine candidate VLA2001 with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).